닫기
Article Search
닫기

Journal of Cancer Prevention

Review

Journal of Cancer Prevention 2016; 21(1): 13-20

Published online March 30, 2016

https://doi.org/10.15430/JCP.2016.21.1.13

© Korean Society of Cancer Prevention

Downregulation of Reactive Oxygen Species in Apoptosis

Chul-Ho Jeong1, and Sang Hoon Joo2

1College of Pharmacy, Keimyung University, Daegu, Gyeongsan, Korea, 2Department of Pharmacy, Catholic University of Daegu, Gyeongsan, Korea

Correspondence to :
Sang Hoon Joo, Department of Pharmacy, Catholic University of Daegu, 13-13 Hayang-ro, Hayang-eup, Gyeongsan 38430, Korea, Tel: +82-53-850-3614, Fax: +82-53-359-6729, E-mail: sjoo@cu.ac.kr, ORCID: Sang Hoon Joo, http://orcid.org/0000-0001-8660-884X

Received: February 17, 2016; Revised: December 28, 2015; Accepted: February 29, 2016

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Go to

Generation of reactive oxygen species (ROS) by diverse anti-cancer drugs or phytochemicals has been closely related with the induction of apoptosis in cancers. Also, the downregulation of ROS by these chemicals has been found to block initiation of carcinogenesis. Therefore, modulation of ROS by phytochemicals emerges as a crucial mechanism to regulate apoptosis in cancer prevention or therapy. This review summarizes the current understanding of the selected chemical compounds and related cellular components that modulate ROS during apoptotic process. Metformin, quercetin, curcumin, vitamin C, and other compounds have been shown to downregulate ROS in the cellular apoptotic process, and some of them even induce apoptosis in cancer cells. The cellular components mediating the downregulation of ROS include nuclear factor erythroid 2-related factor 2 antioxidant signaling pathway, thioredoxin, catalase, glutathione, heme oxygenase-1, and uncoupling proteins. The present review provides information on the relationship between these compounds and the cellular components in modulating ROS in apoptotic cancer cells.

Keywords: Reactive oxygen species, Apoptosis, Neoplasms

INTRODUCTION

Go to

The increase of reactive oxygen species (ROS) is often observed in the progress of apoptosis,1,2 and the generation/upregulation of ROS can be an indication of apoptosis. Indeed, many anticancer drugs and natural compounds (curcumin,3 garlic,4 quercetin,1 cisplatin,5 etc.) have been known to increase the level of ROS as they induce the apoptosis in cancer cells. While the increase of ROS usually correlates with the apoptotic progress, the downregulation of ROS in apoptotic cancer cells is often observed. While it may seem perplexing at first glance, it is plausible considering the beneficial and essential roles of ROS in physiological conditions.

In this review, we have summarized the current understanding of the selected chemical compounds (Fig. 1) and the related cellular components which modulate ROS during the apoptotic process (Fig. 1). The studies on the apoptotic or anti-apoptotic effects of metformin, quercetin, curcumin, vitamin C, and other compounds in diverse cancer cells are presented (Table 1), followed by the cellular components, including nuclear factor-erythroid2-related factor 2 (Nrf2) antioxidant signaling pathway, thioredoxin (TRX), catalase, glutathione (GSH), heme oxygenase-1 (HO-1), and uncoupling proteins (UCPs). We focus here on the cell-specific downregulation of ROS by selected chemicals as a modulator of apoptosis.

NATURAL/SYNTHETIC ANTIOXIDANTS THAT DOWNREGULATE REACTIVE OXYGEN SPECIES

Go to

1. Metformin

Metformin is an oral antidiabetic medication to treat type 2 diabetes. It enhances insulin sensitivity by increasing glucose uptake and utilization in peripheral tissues. These effects are mainly mediated by the activation of AMP-activated protein kinase (AMPK). Quite recently, metformin was suggested to be related with the reduced risk of cancer in diabetic patients.6,7 While the mechanism by which metformin protects against cancer is veiled yet, metformin has been reported to decrease ROS in several cases. Metformin, at the pharmacological level of ∼10?5 mol/L, lowered the level of ROS in bovine aortic endothelial cells.8 The production of ROS in endothelial cells, upon glucose-induction, is mainly mediated by several pathways of hyperglycemic responses, including the activation of protein kinase C (PKC).9 Metformin inhibited the activity of PKC, although it does not have direct inhibitory activity against PKC in vitro. It appears that metformin inhibits the upstream of the activation of PKC, such as membrane translocation of PKC.10 The AMPK pathway, activated by metformin, increased the expression of the TRX through forkhead transcription factor 3, and the TRX functions as antioxidant to reduce the ROS.11 The decrease of ROS could reduce the DNA damage, and possibly the risk of cancer.12 Metformin inhibited the advanced glycation end product-induced apoptosis in renal tubular cells through ROS reduction mediated by the activation of AMPK pathway.13 The role of the AMPK in the reduction of ROS is not essential, as metformin decreases the ROS even in the AMPK-deficient cells.14 Moreover, the protective effect of metformin was observed in the fatty liver cell under oxidative stress, probably due to the increased antioxidant enzyme activity, lower ROS production, and reduction of inflammation.15 While the role of metformin was mostly related with cell protective effects, it was recently reported that metformin decreased the growth of pancreatic cancer cells by reducing ROS production.16

2. Quercetin

Quercetin is a widespread flavonoid compound from numerous vegetables and fruits. At least 50 mg of quercetin is estimated to be present in a daily diet.17 Several clinically relevant functions of quercetin are antihypertensive, anti-inflammatory, hypocholesterolaemic, and antitumor activity.18 Early studies reported quercetin as a mutagenic compound in the Ames test.19,20 However, later studies indicated anticancer activity of quercetin.21,22 Interestingly, quercetin has both pro-oxidative and anti-oxidative properties depending on the redox state of the biological environment.23 In relation with the apoptosis, quercetin induced the generation of ROS, resulting in apoptosis in hepatoma cells24 and leukemia cells.25 Therefore, the pro-apoptotic role of quercetin appears to be related with the upregulation of ROS, not the downregulation. In contrast, the downregulation of ROS by rutin, a quercetin glycoside, was observed in the hydrogen peroxide-induced apoptosis of human umbilical vein endothelial cells.26

3. Curcumin

Curcumin is a yellow pigment obtained from the root of the Indian turmeric (Curcuma longa). It has been used as a foodstuff, cosmetic, and herbal medicine for a long time. The reported biological activities of curcumin include antioxidant, anti-inflammatory,27 anticancer,28 and chemoprevention,29 etc. Curcumin has been reported to induce apoptosis in numerous cells, including human renal Caki cells,3 skin squamous cell carcinoma COLO-16,30 mouse fibroblast L929 cells,31 and human lung adenocarcinoma A549 cells.32 In these cases, the induction of ROS mediated the apoptosis. These pro-apoptotic roles of curcumin seem to be involved in the upregulation of ROS, and the downregulation of ROS inhibited the apoptosis of SH-SY5Y cells.33

4. Vitamin C

Vitamin C is an essential nutrient in human, and it functions as an electron donor for many enzymatic reactions. It is widely accepted that vitamin C is an antioxidant, and the reduction of ROS by vitamin C treatment has been reported in the TRAIL-induced apoptosis34 and the oxidized low density lipoprotein (LDL)-induced apoptosis.35 The reduction of ROS resulted in the protection of the cells from apoptotic damage. On the other hand, vitamin C was not effective in the inhibition of the H2O2-induced apoptosis.36 Interestingly, the H2O2-induced apoptosis was preferably exacerbated by vitamin C.37 Also, vitamin C induced the apoptosis of B16 murine melanoma cells by increasing ROS.38 Therefore, the role of vitamin C as an antioxidant in the apoptosis is controversial.

5. Other compounds

Spirafolide is a compound purified from the leaves of Laurus nobilis L. It has been reported to decrease the ROS level, thereby inhibited dopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.39 Fructose, when used as sole carbon source instead of glucose, reduced ROS and stabilized of cellular GSH pool as efficient as N-acetyl-cystein in the oxidative stress-induced apoptosis in liver parenchymal cells.40

Retinoic acid, a metabolite of vitamin A metabolism, has been shown to suppress ROS production and inhibit the staurosporine-induced apoptosis.41 Previous study indicated that treatment with retinoic acid prevented angiotensin II-induced apoptosis in cardiomyocyte by decreasing ROS generation.42 However, the upregulation of ROS by retinoic acid was also reported in promyelocytic leukemia,43 which resulted in apoptosis of granulocyte-differentiated HL60 cells.44 Consistently, it was accepted that the downregulation of ROS by retinoic acids was related with the prevention of apoptosis.

Dihydromyricetin, a flavonoid compound, was recently shown to induce the apoptosis of human hepatocarcinoma cells by decreasing ROS generation.45,46 In addition, it is noteworthy that the downregulation of the ROS by dihydromyricetin could block H2O2-induced apoptosis of MT-4 lymphocytes47 and PC12 cells.48 These results suggest that the downregulation of ROS can differently modulate apoptosis depending on the cell types.

ENDOGENOUS CELLULAR COMPONENTS INVOLVED WITH THE DOWNREGULATION OF REACTIVE OXYGEN SPECIES

Go to

1. Nuclear factor erythroid 2-related factor 2 antioxidant signaling pathway

Nrf2 is a basic leucine zipper transcriptional activator.49 In non-stressed cells, Nrf2 is constantly degraded through ubiquitin-proteasome pathway mainly regulated by Keap1 protein.50 In the presence of ROS, activated Nrf2 can act as a master regulator of several genes for antioxidant enzymes and detoxifying enzymes by binding activated antioxidant response elements.51 Those enzymes are NAD(P)H:quinone oxidoreductase (NQO1),52 glutathione S-transferase,53 and HO-1.54 The protective role of Nrf2 signaling pathway in the apoptotic process was evident. Nrf2 mediated the expression of HO-1 and NQO1, thereby protected cells from the Cr(VI) induced-apoptosis.55 Upregulation of HO-1 by Nrf2 rescued PC12 cells from H2O2-induced apoptosis.56 Moreover, the presence of Nrf2 increased the level of TRX, thereby protected human dopaminergic neuroblastoma SH-SY5Y cells from the paraquat-induced cell death.57 In addition to antioxidant proteins, Nrf2 also regulated the expression of anti-apoptotic protein Bcl-2.58 While Nrf2 signaling pathway showed the anti-apoptotic effect in most cases, constitutively active Nrf2 enhanced the apoptosis of damaged liver cells.59 It might be possible to modulate the activity of Nrf2 to either protect or damage the cells.60

2. Thioredoxin

TRX is an oxidoreductase enzyme containing dithiol-disulfide active site.61 There are TRX isoforms in most organisms, and there exist separate TRX system for cytoplasm and mitochondria. TRX functions as a protein disulfide reductase and an electron donor for other enzymes such as ribonucleotide reductase and peroxidase.62 Conditional knockout of a mitochondrial enzyme TRX-2 resulted in the induction of apoptosis in chicken B-cell lines, DT40,63 and overexpression of TRX-2 inhibited the TNF-α-induced apoptosis of HeLa cells,64 indicating the anti-apoptotic role of TRX. Moreover, TRX inhibited apoptosis signal-regulating kinase 1 (ASK1) by promoting the ubiquitination of ASK1, demonstrating the role of TRX beyond ROS removal.65 In most cases, TRX has been shown to possess a protective and anti-apoptotic function. However, the pro-apoptotic role of TRX was also reported in the anthracycline-induced apoptosis of MCF-7 breast cancer cells. The expression of the redox-inactive mutant TRX resulted in decreased superoxide generation and apoptosis.66

3. Catalase

Catalase is a peroxisomal enzyme that converts hydrogen peroxide, a ROS, into water and oxygen. Inhibition of catalase can result in the increase in ROS and oxidative damage. Indeed, TGF-β1-induced suppression of the expression/activity of catalase caused the apoptosis of hamster pancreatic beta-cell line.67 On the other hand, the overexpression of catalase could attenuate the apoptosis induced by oxidized LDL stimulation68 and UV-B radiation.69 Catalase showed a protective and anti-apoptotic role in most cases by eliminating ROS. Nevertheless, it was also reported that the overexpression of human catalase inhibited proliferation and promoted the apoptosis of vascular smooth muscle cells.70

4. Glutathione

GSH is a tripeptide compound containing cysteine present in animal, plant, and fungi. It serves as an antioxidant with the free thiol group of cysteine residue. The oxidized form of GSH (GSSG) contains two GSH with disulfide linkage, and the ratio of GSH vs. GSSG can be a good measure of redox state of the cell.71 The protective and anti-apoptotic role of GSH was shown in MDBK bovine renal epithelial cells: the selenium-dependent GSH peroxidase (GPx) protected the cells against the H2O2-induced apoptosis,72 whereas the suppression of GPx enhanced the H2O2-induced apoptosis.67 Therefore, GSH depletion is closely correlated with the apoptotic induction in most cases, and the protective and anti-apoptotic role of GSH might be due to its antioxidant function.

5. Heme oxygenase-1

HO-1 is a stress-responsive enzyme catalyzing the degradation of heme into carbon monoxide (CO), biliverdin, and iron (Fe2+).73 The HO-1-inducing stress stimuli include X-ray-induced oxidative stress,74 hypoxia,75 and ultraviolet.76 All three products of HO-1 reaction serve as antioxidants and have other protective roles against apoptosis. Pharmacological upregulation of HO-1 prevented the glutamate-induced apoptosis of cerebral vascular endothelial cells.77 Upregulation of HO-1 protected human keratinocyte (HaCaT) cells against UV-A?induced oxidative stress.78 However, it does not always imply that the induction of HO-1 plays a protective role in cells against apoptosis, considering that induction of HO-1 increased in the Nickel (II)-induced apoptosis of human Jurkat cells.79 This might be resulted from the response of cells to the increased level of ROS. It appears that the expression of HO-1 has to do with the reduction of ROS as seen in the dihydromyricetin-induced apoptosis of human hepatoma HepG2 cells.45

6. Uncoupling proteins

UCPs are mitochondrial inner membrane proteins, and they dissipate proton gradient. The physiological roles contain heat generation as in hibernation, cold exposure, and normal body temperature. In addition, UCP2 has been shown to modulate the mitochondrial generation of H2O2.80 Splenocytes, resistant to oxidative stress-induced apoptosis, have been reported to show high level of UCP2 expression.81 Overexpression of UCP2 inhibited ROS generation and blocked the apoptosis in human aortic endothelial cells induced by lysophophatidylcholine.82 The inhibition of UCP2, on the contrary, exacerbated the apoptosis in kidney cells.83 Several other reports also supported the anti-apoptotic function of UCP2 through the downregulation of ROS.

CONCLUSION

Go to

We have summarized the controversial role of selected natural/synthetic compounds in modulating cell apoptosis by different regulation of ROS generation. Because the cellular components mediating the downregulation of ROS have not been tied up with corresponding compounds yet, further study in this field is required to establish clearer relationship between these compounds and the cellular components in cancer cells. These natural/synthetic compounds can be useful in modulating the apoptotic process, and in providing new strategies in cancer prevention and therapy.

ACKNOWLEDGMENTS

Go to

This study was supported by College of Pharmacy-specialized Research Fund (from Institute for New Drug Development) of Keimyung University and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2054979).

Tables

Go to
Table. 1.

Cell-specific modulation of ROS generation by selected compounds.

CompoundCell typeEffect on ROSCellular effectReference
MetforminRenal tubular cells, fatty liver cellsDecreaseAnti-apoptotic13, 15
MetforminPancreatic cancer cellsDecreaseApoptotic16
QuercetinHepatoma, leukemiaIncreaseApoptotic24, 25
QuercetinHUVEC cellsDecreaseAnti-apoptotic26
CurcuminRenal, skin, fibroblast, lung adenocarcinomaDecreaseAnti-apoptotic3, 30, 31, 32
CurcuminNeuroblastomaIncreaseApoptotic33
Vitamin CWISHDecreaseAnti-apoptotic36
Vitamin CB16 murine cellsIncreaseApoptotic38
SpirafolideNeuroblastomaDecreaseAnti-apoptotic39
Retinoic acidNeuron, cardiomyocyteDecreaseAnti-apoptotic41, 42
Retinoic acidHL60 cellsIncreaseApoptotic44
DihydromyricetinHepatocarcinomaDecreaseApoptotic45, 46
DihydromyricetinLymphocytes, PC12DecreaseAnti-apoptotic47, 48

ROS, reactive oxygen species..

References

Go to
  1. Mat?s, JM, and S?nchez-Jim?nez, FM (2000). Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol. 32, 157-70.
    Pubmed CrossRef
  2. Simon, HU, Haj-Yehia, A, and Levi-Schaffer, F (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5, 415-8.
    CrossRef
  3. Woo, JH, Kim, YH, Choi, YJ, Kim, DG, Lee, KS, and Bae, JH (2003). Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 24, 1199-208.
    Pubmed CrossRef
  4. Dirsch, VM, Gerbes, AL, and Vollmar, AM (1998). Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB. Mol Pharmacol. 53, 402-7.
    Pubmed
  5. Berndtsson, M, H?gg, M, Panaretakis, T, Havelka, AM, Shoshan, MC, and Linder, S (2007). Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA. Int J Cancer. 120, 175-80.
    CrossRef
  6. Evans, JM, Donnelly, LA, Emslie-Smith, AM, Alessi, DR, and Morris, AD (2005). Metformin and reduced risk of cancer in diabetic patients. BMJ. 330, 1304-5.
    Pubmed KoreaMed CrossRef
  7. Decensi, A, Puntoni, M, Goodwin, P, Cazzaniga, M, Gennari, A, and Bonanni, B (2010). Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila). 3, 1451-61.
    CrossRef
  8. Ouslimani, N, Peynet, J, Bonnefont-Rousselot, D, Th?rond, P, Legrand, A, and Beaudeux, JL (2005). Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism. 54, 829-34.
    Pubmed CrossRef
  9. Nishikawa, T, Edelstein, D, Du, XL, Yamagishi, S, Matsumura, T, and Kaneda, Y (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 404, 787-90.
    Pubmed CrossRef
  10. Mahrouf, M, Ouslimani, N, Peynet, J, Djelidi, R, Couturier, M, and Therond, P (2006). Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol. 72, 176-83.
    Pubmed CrossRef
  11. Hou, X, Song, J, Li, XN, Zhang, L, Wang, X, and Chen, L (2010). Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun. 396, 199-205.
    Pubmed CrossRef
  12. Algire, C, Moiseeva, O, Desch?nes-Simard, X, Amrein, L, Petruccelli, L, and Birman, E (2012). Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev Res (Phila). 5, 536-43.
    CrossRef
  13. Ishibashi, Y, Matsui, T, Takeuchi, M, and Yamagishi, S (2012). Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. Horm Metab Res. 44, 891-5.
    Pubmed CrossRef
  14. Kelly, B, Tannahill, GM, Murphy, MP, and O’Neill, LA (2015). Metformin inhibits the production of reactive oxygen species from NADH: ubiquinone oxidoreductase to limit induction of interleukin-1β (IL-1β) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. J Biol Chem. 290, 20348-59.
    Pubmed KoreaMed CrossRef
  15. Cahova, M, Palenickova, E, Dankova, H, Sticova, E, Burian, M, and Drahota, Z (2015). Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. Am J Physiol Gastrointest Liver Physiol. 309, G100-11.
    Pubmed CrossRef
  16. Cheng, G, and Lanza-Jacoby, S (2015). Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4. Biochem Biophys Res Commun. 465, 41-6.
    Pubmed CrossRef
  17. Brown, JP (1980). A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res. 75, 243-77.
    Pubmed CrossRef
  18. Formica, JV, and Regelson, W (1995). Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol. 33, 1061-80.
    Pubmed CrossRef
  19. Bjeldanes, LF, and Chang, GW (1977). Mutagenic activity of quercetin and related compounds. Science. 197, 577-8.
    Pubmed CrossRef
  20. Rueff, J, Laires, A, Gaspar, J, Borba, H, and Rodrigues, A (1992). Oxygen species and the genotoxicity of quercetin. Mutat Res. 265, 75-81.
    Pubmed CrossRef
  21. Chang, RL, Huang, MT, Wood, AW, Wong, CQ, Newmark, HL, and Yagi, H (1985). Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/?)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis. 6, 1127-33.
    Pubmed CrossRef
  22. Nixon, JE, Hendricks, JD, Pawlowski, NE, Pereira, CB, Sinnhuber, RO, and Bailey, GS (1984). Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compounds. Carcinogenesis. 5, 615-9.
    Pubmed CrossRef
  23. Sahu, SC, and Washington, MC (1992). Effect of ascorbic acid and curcumin on quercetin-induced nuclear DNA damage, lipid peroxidation and protein degradation. Cancer Lett. 63, 237-41.
    Pubmed CrossRef
  24. Chang, YF, Chi, CW, and Wang, JJ (2006). Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells. Nutr Cancer. 55, 201-9.
    Pubmed CrossRef
  25. Lee, WJ, Hsiao, M, Chang, JL, Yang, SF, Tseng, TH, and Cheng, CW (2015). Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft. Arch Toxicol. 89, 1103-17.
    CrossRef
  26. Gong, G, Qin, Y, Huang, W, Zhou, S, Yang, X, and Li, D (2010). Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells. Eur J Pharmacol. 628, 27-35.
    CrossRef
  27. Menon, VP, and Sudheer, AR (2007). Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 595, 105-25.
    Pubmed CrossRef
  28. Agrawal, DK, and Mishra, PK (2010). Curcumin and its analogues: potential anticancer agents. Med Res Rev. 30, 818-60.
  29. Jiao, Y, Wilkinson, J, Di, X, Wang, W, Hatcher, H, and Kock, ND (2009). Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. 113, 462-9.
    KoreaMed CrossRef
  30. Hail, N (2008). Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radic Biol Med. 44, 1382-93.
    Pubmed CrossRef
  31. Thayyullathil, F, Chathoth, S, Hago, A, Patel, M, and Galadari, S (2008). Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic Biol Med. 45, 1403-12.
    Pubmed CrossRef
  32. Chen, Q, Wang, Y, Xu, K, Lu, G, Ying, Z, and Wu, L (2010). Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Oncol Rep. 23, 397-403.
    Pubmed CrossRef
  33. U?uz, AC, ?z, A, and Nazıro?lu, M (). Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells. [published online ahead of print November 25, 2015]. J Recept Signal Transduct Res.
    CrossRef
  34. Perez-Cruz, I, C?rcamo, JM, and Golde, DW (2007). Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase. Apoptosis. 12, 225-34.
    CrossRef
  35. Siow, RC, Richards, JP, Pedley, KC, Leake, DS, and Mann, GE (1999). Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol. 19, 2387-94.
    Pubmed CrossRef
  36. Kumar, D, Lundgren, DW, Moore, RM, Silver, RJ, and Moore, JJ (2004). Hydrogen peroxide induced apoptosis in amnion-derived WISH cells is not inhibited by vitamin C. Placenta. 25, 266-72.
    Pubmed CrossRef
  37. Kumar, D, Moore, RM, Elkhwad, M, Silver, RJ, and Moore, JJ (2004). Vitamin C exacerbates hydrogen peroxide induced apoptosis and concomitant PGE2 release in amnion epithelial and mesenchymal cells, and in intact amnion. Placenta. 25, 573-9.
    Pubmed CrossRef
  38. Kang, JS, Cho, D, Kim, YI, Hahm, E, Yang, Y, and Kim, D (2003). L-ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8-independent pathway. Cancer Immunol Immunother. 52, 693-8.
    Pubmed CrossRef
  39. Ham, A, Kim, B, Koo, U, Nam, KW, Lee, SJ, and Kim, KH (2010). Spirafolide from bay leaf (Laurus nobilis) prevents dopamine-induced apoptosis by decreasing reactive oxygen species production in human neuroblastoma SH-SY5Y cells. Arch Pharm Res. 33, 1953-8.
    Pubmed CrossRef
  40. Frenzel, J, Richter, J, and Eschrich, K (2002). Fructose inhibits apoptosis induced by reoxygenation in rat hepatocytes by decreasing reactive oxygen species via stabilization of the glutathione pool. Biochim Biophys Acta. 1542, 82-94.
    Pubmed CrossRef
  41. Ahlemeyer, B, and Krieglstein, J (1998). Retinoic acid reduces staurosporine-induced apoptotic damage in chick embryonic neurons by suppressing reactive oxygen species production. Neurosci Lett. 246, 93-6.
    Pubmed CrossRef
  42. Choudhary, R, Baker, KM, and Pan, J (2008). All-trans retinoic acid prevents angiotensin II- and mechanical stretch-induced reactive oxygen species generation and cardiomyocyte apoptosis. J Cell Physiol. 215, 172-81.
    CrossRef
  43. Ohno, E, Ohtsuka, E, Saburi, Y, Ono, K, Kikuchi, H, and Nasu, M (1999). Reactive oxygen species production of neutrophils in patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Am J Hematol. 62, 120-1.
    Pubmed CrossRef
  44. Wang, CY, Yang, TT, Chen, CL, Lin, WC, and Lin, CF (2014). Reactive oxygen species-regulated glycogen synthase kinase-3β activation contributes to all-trans retinoic acid-induced apoptosis in granulocyte-differentiated HL60 cells. Biochem Pharmacol. 88, 86-94.
    Pubmed CrossRef
  45. Liu, B, Tan, X, Liang, J, Wu, S, Liu, J, and Zhang, Q (2014). A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells. Sci Rep. 4, 7041.
    Pubmed KoreaMed CrossRef
  46. Liu, B, Zhou, W, Chen, X, Xu, F, Chen, Y, and Liu, J (2015). Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway. Mol Med Rep. 11, 1609-14.
  47. Ye, J, Guan, Y, Zeng, S, and Liu, D (2008). Ampelopsin prevents apoptosis induced by H2O2 in MT-4 lymphocytes. Planta Med. 74, 252-7.
    Pubmed CrossRef
  48. Kou, X, Shen, K, An, Y, Qi, S, Dai, WX, and Yin, Z (2012). Ampelopsin inhibits H2O2-induced apoptosis by ERK and Akt signaling pathways and up-regulation of heme oxygenase-1. Phytother Res. 26, 988-94.
    CrossRef
  49. Moi, P, Chan, K, Asunis, I, Cao, A, and Kan, YW (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A. 91, 9926-30.
    Pubmed KoreaMed CrossRef
  50. Nguyen, T, Sherratt, PJ, Nioi, P, Yang, CS, and Pickett, CB (2005). Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem. 280, 32485-92.
    Pubmed CrossRef
  51. Nguyen, T, Nioi, P, and Pickett, CB (2009). The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 284, 13291-5.
    Pubmed KoreaMed CrossRef
  52. Ma, Q, Kinneer, K, Bi, Y, Chan, JY, and Kan, YW (2004). Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap ‘n’ collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem J. 377, 205-13.
    CrossRef
  53. Ikeda, H, Serria, MS, Kakizaki, I, Hatayama, I, Satoh, K, and Tsuchida, S (2002). Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen. Biochem J. 364, 563-70.
    Pubmed KoreaMed CrossRef
  54. Alam, J, Stewart, D, Touchard, C, Boinapally, S, Choi, AM, and Cook, JL (1999). Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem. 274, 26071-8.
    Pubmed CrossRef
  55. He, X, Lin, GX, Chen, MG, Zhang, JX, and Ma, Q (2007). Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association. Toxicol Sci. 98, 298-309.
    Pubmed CrossRef
  56. Kim, JW, Li, MH, Jang, JH, Na, HK, Song, NY, and Lee, C (2008). 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. Biochem Pharmacol. 76, 1577-89.
    Pubmed CrossRef
  57. Niso-Santano, M, Gonz?lez-Polo, RA, Bravo-San Pedro, JM, G?mez-S?nchez, R, Lastres-Becker, I, and Ortiz-Ortiz, MA (2010). Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis. Free Radic Biol Med. 48, 1370-81.
    Pubmed CrossRef
  58. Niture, SK, and Jaiswal, AK (2012). Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem. 287, 9873-86.
    Pubmed KoreaMed CrossRef
  59. K?hler, UA, Kurinna, S, Schwitter, D, Marti, A, Sch?fer, M, and Hellerbrand, C (2014). Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis. Hepatology. 60, 670-8.
    CrossRef
  60. Li, W, Khor, TO, Xu, C, Shen, G, Jeong, WS, and Yu, S (2008). Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol. 76, 1485-9.
    Pubmed KoreaMed CrossRef
  61. Wollman, EE, d’Auriol, L, Rimsky, L, Shaw, A, Jacquot, JP, and Wingfield, P (1988). Cloning and expression of a cDNA for human thioredoxin. J Biol Chem. 263, 15506-12.
    Pubmed
  62. Arn?r, ES, and Holmgren, A (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 267, 6102-9.
    Pubmed CrossRef
  63. Tanaka, T, Hosoi, F, Yamaguchi-Iwai, Y, Nakamura, H, Masutani, H, and Ueda, S (2002). Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 21, 1695-703.
    Pubmed KoreaMed CrossRef
  64. Hansen, JM, Zhang, H, and Jones, DP (2006). Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci. 91, 643-50.
    Pubmed CrossRef
  65. Liu, Y, and Min, W (2002). Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res. 90, 1259-66.
    Pubmed CrossRef
  66. Ravi, D, Muniyappa, H, and Das, KC (2005). Endogenous thioredoxin is required for redox cycling of anthracyclines and p53-dependent apoptosis in cancer cells. J Biol Chem. 280, 40084-96.
    Pubmed CrossRef
  67. Islam, KN, Kayanoki, Y, Kaneto, H, Suzuki, K, Asahi, M, and Fujii, J (1997). TGF-beta1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radic Biol Med. 22, 1007-17.
    Pubmed CrossRef
  68. Lin, SJ, Shyue, SK, Liu, PL, Chen, YH, Ku, HH, and Chen, JW (2004). Adenovirus-mediated overexpression of catalase attenuates oxLDL-induced apoptosis in human aortic endothelial cells via AP-1 and C-Jun N-terminal kinase/extracellular signal-regulated kinase mitogen-activated protein kinase pathways. J Mol Cell Cardiol. 36, 129-39.
    Pubmed CrossRef
  69. Rezvani, HR, Mazurier, F, Cario-Andr?, M, Pain, C, Ged, C, and Ta?eb, A (2006). Protective effects of catalase overexpression on UVB-induced apoptosis in normal human keratinocytes. J Biol Chem. 281, 17999-8007.
    Pubmed CrossRef
  70. Brown, MR, Miller, FJ, Li, WG, Ellingson, AN, Mozena, JD, and Chatterjee, P (1999). Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res. 85, 524-33.
    Pubmed KoreaMed CrossRef
  71. Halprin, KM, and Ohkawara, A (1967). The measurement of glutathione in human epidermis using glutathione reductase. J Invest Dermatol. 48, 149-52.
    Pubmed CrossRef
  72. Kayanoki, Y, Fujii, J, Islam, KN, Suzuki, K, Kawata, S, and Matsuzawa, Y (1996). The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species. J Biochem. 119, 817-22.
    Pubmed CrossRef
  73. Soares, MP, and Bach, FH (2009). Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med. 15, 50-8.
    Pubmed CrossRef
  74. Risom, L, Møller, P, Vogel, U, Kristjansen, PE, and Loft, S (2003). X-ray-induced oxidative stress: DNA damage and gene expression of HO-1, ERCC1 and OGG1 in mouse lung. Free Radic Res. 37, 957-66.
    Pubmed CrossRef
  75. Garnier, P, Demougeot, C, Bertrand, N, Prigent-Tessier, A, Marie, C, and Beley, A (2001). Stress response to hypoxia in gerbil brain: HO-1 and Mn SOD expression and glial activation. Brain Res. 893, 301-9.
    Pubmed CrossRef
  76. Wu, Z, Uchi, H, Morino-Koga, S, Shi, W, and Furue, M (2015). Z-ligustilide ameliorated ultraviolet B-induced oxidative stress and inflammatory cytokine production in human keratinocytes through upregulation of Nrf2/HO-1 and suppression of NF-κB pathway. Exp Dermatol. 24, 703-8.
    Pubmed CrossRef
  77. Parfenova, H, Basuroy, S, Bhattacharya, S, Tcheranova, D, Qu, Y, and Regan, RF (2006). Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol Cell Physiol. 290, C1399-410.
    CrossRef
  78. Hseu, YC, Chou, CW, Senthil Kumar, KJ, Fu, KT, Wang, HM, and Hsu, LS (2012). Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem Toxicol. 50, 1245-55.
    Pubmed CrossRef
  79. Zhang, D, Shen, J, Wang, C, Zhang, X, and Chen, J (2009). GSH-dependent iNOS and HO-1 mediated apoptosis of human Jurkat cells induced by nickel(II). Environ Toxicol. 24, 404-14.
    CrossRef
  80. N?gre-Salvayre, A, Hirtz, C, Carrera, G, Cazenave, R, Troly, M, and Salvayre, R (1997). A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J. 11, 809-15.
    Pubmed
  81. Cao, T, Dong, Y, Tang, R, Chen, J, Zhang, CY, and Zen, K (2013). Mitochondrial uncoupling protein 2 protects splenocytes from oxidative stress-induced apoptosis during pathogen activation. Cell Immunol. 286, 39-44.
    Pubmed CrossRef
  82. Lee, KU, Lee, IK, Han, J, Song, DK, Kim, YM, and Song, HS (2005). Effects of recombinant adenovirus-mediated uncoupling protein 2 over-expression on endothelial function and apoptosis. Circ Res. 96, 1200-7.
    Pubmed CrossRef
  83. Chen, XL, Tang, WX, Tang, XH, Qin, W, and Gong, M (2014). Downregulation of uncoupling protein-2 by genipin exacerbates diabetes-induced kidney proximal tubular cells apoptosis. Ren Fail. 36, 1298-303.
    Pubmed CrossRef

Article Tools

Metrics

Share this article on :

Related articles in JCP

Most KeyWord